Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis Health Authority Inspections by Year
Novartis Health Authority Inspections: 140 in FY2025, up 1.4% from a year earlier.
Latest, FY2025
140
Period ended Dec 31, 2025
Change on a year earlier
+1.4%
138 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf
Where the FY2025 figure comes from
“| Total inspections | 140 | 138 | ∆ | 27 |”
Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
Reported in ESG Data Summary 2025 & Nonfinancial Report.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Health Authority Inspections | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 140 | +1.4% | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
| FY2024 | Dec 31, 2024 | 138 | – | Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗ |
Breakdown
What makes up health Authority Inspections
Cite this data
StockData. (2026). Novartis Health Authority Inspections, annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/qual-ha-inspections-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.